Amgen · 1 day ago
CD&A - Forecasting Senior Manager, Rare Disease
Chicago, IL
Full-time
Hybrid
Mid, Senior Level
4+ years expAmgen is a biotechnology company dedicated to serving patients living with serious illnesses. The Senior Manager of Forecasting will play a crucial role in the Rare Disease business by developing and managing forecasts, collaborating with cross-functional teams, and providing insights to drive commercial success.
BiotechnologyHealth CareManufacturingPharmaceutical
Responsibilities
Build and maintain robust forecasting models using advanced techniques (trend analysis, regression, scenario planning)
Incorporate internal and external data (sales trends, competitive landscape, market research) to refine forecasts
Conduct regular forecast reviews and adjust as needed based on market dynamics, sales performance and strategic changes
Collaborate with cross-functional teams to align forecasts with business strategies
Provide insights on performance drivers and potential risks and opportunities impacting the forecasts
Evaluate and report the impact of market events (competitor launches, regulatory changes) on product performance
Present forecasts and supporting insights to senior leadership and other stakeholders
Work closely with supply chain teams to ensure forecasts align with inventory and operational planning
Serve as the subject matter expert on forecast assumptions and methodologies
Leverage data visualization tools (Tableau, Power BI) to communicate insights effectively
Utilize forecasting software and statistical tools to improve accuracy and efficiency
Continuously explore and implement new data sources and analytical techniques to enhance forecasting processes
Oversight of one contingent worker
Qualification
Required
Doctorate degree and 2 years of forecasting, analytics or finance experience
Master's degree and 4 years of forecasting, analytics or finance experience
Bachelor's degree and 6 years of forecasting, analytics or finance experience
Associate's degree and 10 years of forecasting, analytics or finance experience
High school diploma / GED and 12 years of forecasting, analytics or finance experience
Preferred
Ability to quickly establish credibility with and influence ED/VP level staff
Knowledge and experience working with industry internal and secondary data sources; experience doing analog and uptake curve analysis
Proficiency in advanced forecasting techniques, statistical modeling and data analysis
Highly skilled in working collaboratively in a team-based environment and gaining alignment across an organization
High level of proficiency in Excel, PowerPoint and Power BI
Excellent communication skills with the ability to present complex data and insights to both technical and non-technical stakeholders
Partnership with business leaders to deliver high-quality predictions guiding strategic decision-making
Ability to interpret and analyze data trends, identify patterns and make data-driven decisions
Experience with Monte Carlo analysis and statistical trending
Benefits
A comprehensive employee benefits package, including a Retirement and Savings Plan with generous company contributions
Group medical, dental and vision coverage
Life and disability insurance
Flexible spending accounts
A discretionary annual bonus program, or for field sales representatives, a sales-based incentive plan
Stock-based long-term incentives
Award-winning time-off plans
Flexible work models, including remote and hybrid work arrangements, where possible
Company
Amgen
Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases.
10001+ employees
H1B Sponsorship
Amgen has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (429)
2024 (485)
2023 (485)
2022 (540)
2021 (460)
2020 (444)
Funding
Current Stage
Public CompanyTotal Funding
$28.5B2022-12-12Post Ipo Debt· $28.5B
1983-06-17IPO
Leadership Team
Robert Bradway
Chairman and Chief Executive Officer
Jay Bradner
Executive Vice President of R&D, and Chief Scientific Officer
Recent News
The Motley Fool
2026-01-09
2026-01-09
BioWorld Financial Watch
2026-01-09
Company data provided by crunchbase